Independent prognostic und predictive value of blood vessel invasion (BVI) in curatively (R0) resected stage II and IIIA non-small cell lung (NSCLC) cancer patients Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012
Analysis of surgical stage lung cancer and tumour markers prognostic value Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006
Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer Source: Eur Respir J 2013; 41: 649-655 Year: 2013
Survival of patients after complete surgical resection in NSCLC stage IV with solitary metastases Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
Occult N2 disease after surgical resection for clinical stage I NSCLC: factors affecting survival Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009
Prognostic factors in patients with resected pathologic stage I and II nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 269s Year: 2002
Intratumoral microvessels, pTNM stage and survival in resected NSCLC Source: Eur Respir J 2005; 26: Suppl. 49, 325s Year: 2005
The prognostic impact of stage and performance status on surgically resected non-small cell lung cancer Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Chemoradiotherapy with or without surgical resection for stage III NSCLC Source: Breathe 2010; 6: 275 Year: 2010
Is the highest mediastinal lymph node a prognostic factor in stage IIIA N2 NSCLC? Source: ISSN=ISSN 1810-6838, ISBN=, page=355 Year: 2006
Identification of p-stage I NSCLC patients with high risk of recurrence and poor prognosis by tumor marker index (TMI) Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011
Independent validation of prognostic value of 22 microRNAs (miRs) in stage I-II lung adenocarcinoma (AC) Source: Annual Congress 2012 - New mechanisms in non-neoplastic and neoplastic lung diseases Year: 2012
Prognostic factors in pathological stage IB nonsmall cell lung cancer greater than 3 cm Source: Eur Respir J 2010; 36: 1355-1361 Year: 2010
Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012
An audit of prognostic significance of histological subtype in surgically resected adenocarcinomas Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016
Usefulness of surgical staging after negative EBUS -staging in patients with lung cancer with clinical N0. Source: International Congress 2019 – General thoracic surgery Year: 2019
The prognostic value of the expression of GST-π in response to chemotherapy in cytological and pathological specimens of patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 74s Year: 2002
Validity of predictive estimate by physicians of the survival of patients with recently diagnosed stages IIIB and IV non-small cells lung cancer (NSCLC) Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007
Correlation between clinical and pathological staging in resectable NSCLC - analysis on 360 surgical cases Source: Eur Respir J 2001; 18: Suppl. 33, 131s Year: 2001
Immunohistochemical study of intratumoral micro vessels in resected non-small cell lung carcinomas, N-status, pTNM-stage and survival period of the patients Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007